Review for "A Multicenter, Randomized, Controlled, Open-Label Study of Continuous Subcutaneous Insulin Infusion Plus Henagliflozin for Treating Type 2 Diabetes Mellitus Patients with Severe Hyperglycemia"
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Publication details
- Journal / source
- Publons reviews and discussion
- Publication date
- 22 January 2026
- Language
- EN